Related Experiment Video
Updated: Jul 4, 2025

08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
11.0K
Identification of Potent siRNA Delivery Peptides Using Computer Modeling
Ke Men1, Mohan Liu1, Xueyan Zhang1
1Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|February 4, 2024
Summary
Researchers developed a computer modeling and single-cell RNA sequencing program to identify ideal peptide-based siRNA delivery vectors. The leading peptide candidate demonstrated effective lung-targeted delivery and strong anticancer effects with minimal tissue damage.
Area of Science:
- Biotechnology
- Molecular Biology
- Drug Delivery Systems
Background:
- Peptides are promising siRNA delivery vectors due to their aggregation and electrical properties.
- Identifying peptides with optimal delivery and safety profiles is challenging due to sequence variability.
Purpose of the Study:
- To develop a computational and experimental program for identifying ideal siRNA delivery peptides.
- To evaluate the in vivo safety and efficacy of candidate peptides.
Main Methods:
- A holistic program combining computer modeling and single-cell RNA sequencing (scRNA-seq) was employed.
- Sequential screening identified peptides with ideal assembly and delivery abilities.
- Cell subtype-level analysis assessed in vivo tissue safety.
Main Results:
- A 12-amino acid peptide, after hydrophobic modification, exhibited strong lung-targeted siRNA delivery.
- Systemic administration showed minimal damage to liver and lung tissues and preserved immune cell populations.
- STAT3 siRNA loading resulted in significant anticancer effects in patient-derived xenograft models.
Conclusions:
- The developed screening procedure effectively identifies safe and effective peptide-based siRNA delivery vectors.
- This approach facilitates the advancement of peptide-based RNA interference (RNAi) therapeutics.
- The leading peptide candidate shows potential for targeted cancer therapy with reduced toxicity.
Related Concept Videos
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K

